Sowell Financial Services LLC Halozyme Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$38.84 - $51.31 $105,023 - $138,742	-2,704 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$39.51 - $51.45 $39,233 - $51,089	-993 Reduced 26.86%	2,704 $129,000
Q4 2020 Jan 13, 2021	SELL	$25.81 - $43.62 $12,440 - $21,024	-482 Reduced 11.53%	3,697 $158,000
Q3 2020 Nov 12, 2020	SELL	$25.74 - $29.63 $59,691 - $68,711	-2,319 Reduced 35.69%	4,179 $110,000
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $91,617 - $151,154	5,638 Added 655.58%	6,498 $174,000
Q4 2019 Feb 07, 2020	SELL	$14.93 - $19.53 $2,762 - $3,613	-185 Reduced 17.7%	860 $15,000
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $15,884 - $18,486	1,045 New	1,045 $16,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.